灵康药业：2025年半年度公司实现营业收入171607603.84元

Core Insights - Lingkang Pharmaceutical reported a revenue of 171,607,603.84 yuan for the first half of 2025, representing a year-on-year growth of 21.30% [2] - The net profit attributable to shareholders of the listed company was -35,733,685.77 yuan [2] Financial Performance - The company's revenue for the first half of 2025 was 171.61 million yuan, showing a growth of 21.30% compared to the previous year [2] - The net profit for the same period was negative, amounting to -35.73 million yuan [2]